Global X Aging Population ETF Rating $32.14 +0.21 (+0.66%) Closing price 03:47 PM EasternExtended Trading$32.14 0.00 (0.00%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock Global X Aging Population ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy 2.69Holdings in AGNG have an aggregate rating of Moderate Buy based on 539 analyst ratings issued in the past year covering 31 companies (56.5% of the portfolio).AGNG Aggregate Price Target$32.14High Prediction$32.14Average Prediction$32.14Low Prediction$32.14Holdings in AGNG have an aggregate price target of $32.14 and a range of $32.14 to $32.14 covering 31 companies (56.5% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 AGNG Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.06%WELLWelltower$157.53+0.5%4.6856 of 5 stars2.92$168.18 6.8%12Positive News3.05%BSXBoston Scientific$103.12-0.4%4.613 of 5 stars3.13$116.09 12.6%24Upcoming Earnings3.02%SYKStryker$390.65+0.0%4.4447 of 5 stars2.79$428.55 9.7%19Positive NewsAnalyst Forecast3.01%EWEdwards Lifesciences$76.15-0.9%4.3568 of 5 stars2.48$81.00 6.4%27Positive NewsUpcoming EarningsAnalyst Forecast2.98%AZNAstraZeneca$70.08-0.3%3.7225 of 5 stars2.83$89.00 27.0%6Trending NewsAnalyst Revision2.95%LLYEli Lilly and Company$788.91+2.2%4.9753 of 5 stars2.75$1,012.56 28.3%20Trending NewsAnalyst Revision2.88%ABBVAbbVie$190.53+2.2%4.7786 of 5 stars2.81$211.29 10.9%27Trending NewsAnalyst Revision2.86%MDTMedtronic$89.74+0.6%4.4623 of 5 stars2.59$98.19 9.4%22Positive NewsAnalyst ForecastAnalyst Revision2.82%AMGNAmgen$299.02+2.2%4.3973 of 5 stars2.35$307.82 2.9%23Trending NewsAnalyst Revision2.74%JNJJohnson & Johnson$164.78+6.2%4.7716 of 5 stars2.55$171.00 3.8%20Trending NewsEarnings ReportDividend AnnouncementOptions VolumeGap UpHigh Trading Volume2.74%MRKMerck & Co., Inc.$82.45+1.1%4.9978 of 5 stars2.43$108.69 31.8%21Positive News2.53%DXCMDexCom$84.13-0.8%4.7821 of 5 stars2.91$99.60 18.4%22Positive NewsAnalyst Forecast2.51%REGNRegeneron Pharmaceuticals$547.930.0%4.8047 of 5 stars2.80$814.57 48.7%252.41%BMYBristol Myers Squibb$47.16+1.6%4.8945 of 5 stars2.32$57.69 22.3%22Analyst Revision2.18%VTRVentas$65.49+0.5%4.4166 of 5 stars3.00$72.90 11.3%12Insider Trade1.99%ONCBeOne Medicines$279.16+3.5%2.4948 of 5 stars3.00$324.89 16.4%7Analyst Forecast1.69%PODDInsulet$288.27-0.6%4.5651 of 5 stars2.83$321.00 11.4%18Positive NewsAnalyst Revision1.43%ZBHZimmer Biomet$94.20+0.2%4.9499 of 5 stars2.35$111.39 18.3%20News CoverageAnalyst Upgrade1.05%INCYIncyte$69.23+1.4%4.6752 of 5 stars2.22$74.47 7.6%18Trending NewsAnalyst ForecastInsider TradeAnalyst Revision1.04%UTHRUnited Therapeutics$298.16+1.7%4.9865 of 5 stars2.69$383.08 28.5%13Positive NewsInsider Trade1.00%NBIXNeurocrine Biosciences$133.48+1.7%4.4935 of 5 stars2.87$163.91 22.8%23Trending NewsAnalyst Revision0.90%EXELExelixis$44.81+1.7%4.7568 of 5 stars2.52$45.28 1.0%21Analyst Forecast0.86%DVADaVita$140.23-0.2%4.4184 of 5 stars2.00$164.50 17.3%6Positive News0.83%OHIOmega Healthcare Investors$37.96-0.1%4.0963 of 5 stars2.44$42.25 11.3%9Positive NewsAnalyst Upgrade0.77%EXASExact Sciences$53.67+1.3%4.6736 of 5 stars2.95$70.50 31.4%220.71%ENSGThe Ensign Group$139.85-0.9%4.9244 of 5 stars2.83$163.50 16.9%6Positive News0.65%BPMCBlueprint Medicines$129.28-0.1%1.0941 of 5 stars2.24$128.25 -0.8%21Positive NewsHigh Trading Volume0.52%HALOHalozyme Therapeutics$58.01+2.5%4.8376 of 5 stars2.17$62.70 8.1%12Positive NewsAnalyst Forecast0.46%GKOSGlaukos$98.51+0.3%4.3346 of 5 stars2.75$134.67 36.7%12Analyst Forecast0.45%CGONCG Oncology$26.08+4.5%2.7577 of 5 stars3.08$55.30 112.0%12News CoveragePositive NewsAnalyst Forecast0.44%ACADACADIA Pharmaceuticals$22.55+2.5%4.1007 of 5 stars2.71$27.88 23.6%17Analyst Revision This page (NASDAQ:AGNG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Aging Population ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.